Aim to assess prognostic value of clinical and instrumental parameters, results of
noninvasive electrophysiological tests and biomarkers as predictors of malignant ventricular …

Background: Prediction and potential prevention of sudden cardiac death (SCD) due to
malignant ventricular arrhythmia (MVA) represent an obvious unmet medical need. We …

Background: There is increasing evidence that an open infarct-related artery results in
increased electrical stability of the heart and that this effect is at least in part responsible for …

Ventricular arrhythmias represent a common problem for the clinical cardiologist in everyday
practice. 1-5 Apart from being commonly asymptomatic, they may manifest with a variety of …

Malignant arrhythmia and sudden death are one of the greatest challenges in cardiology. In
prevention, it is important to correctly select patients under risk. Simple and non-invasive …

The role of the signal‐averaged ECG was prospectively assessed in 517 patients in whom
there was a suspicion for malignant ventricular arrhythmias. Patients were divided into …

Recent studies clearly support the role of the cardioverter implantable defibrillator in
reducing arrhythmic and all-cause mortality in patients with a previous myocardial infarction …

Fifty percent of deaths associated with acute myocardial infarction are attributable to
ventricular arrhythmias and sudden death. Lethal ventricular arrhythmias are caused by an …

Malignant ventricular arrhythmias are a major adverse event and worsen the prognosis of
patients affected by ischemic and non-ischemic dilated cardiomyopathy. The main …

Recent studies have identified several electrocardiographic parameters that may aid in
distinguishing between malignant and benign idiopathic ventricular arrhythmias. These …